Primary malignant melanoma of the esophagus: long-term survival following pre- and postoperative adjuvant hormone/chemotherapy.
Uetsuka
Hirokazu
H
Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikatacho, Okayama 700-8558, Japan.
Naomoto
Yoshio
Y
Fujiwara
Toshiya
T
Shirakawa
Yasuhiro
Y
Noguchi
Hirofumi
H
Yamatsuji
Tomoki
T
Haisa
Minoru
M
Matsuoka
Junji
J
Gunduz
Mehmet
M
Takubo
Kaiyo
K
Tanaka
Noriaki
N
D000276:Adjuvants, Immunologic; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology / Q000601:surgery*; D016629:Esophagectomy / Q000379:methods; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008197:Lymph Node Excision; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D008875:Middle Aged; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D016899:Interferon-beta